Cite
HARVARD Citation
Belani, C. et al. (2016). Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive‐stage small cell lung cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E1508). Cancer. 122 (15), pp. 2371-2378. [Online].